Generic drug industry blue ribbon panel

Executive Summary

Lead-off speakers at June 20 hearing are Center for Drug Evaluation and Research Director Carl Peck, MD, and Office of Generic Drugs Acting Director Bruce Burlington, MD, followed by speakers representing the generic industry, testing labs, health insurers and medical professional societies. Established by the Generic Pharmaceutical Industry Association and chaired by former PMA President Lewis Engman, the panel convenes at 9:00 a.m. at the Georgetown University Hotel and Conference Center in Washington, D.C.